Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stellar Biotechnologies developed proprietary aquaculture and extraction technologies to sustainably produce GMP-grade Keyhole Limpet Hemocyanin (KLH), which is used globally as a carrier protein/adjuvant in clinical-stage immunotherapies against cancer, autoimmune diseases, Alzheimer’s disease, and more. Their technology enabled repeated non-lethal extraction from captive limpets—a unique capability—positioning them as the world leader in sustainable pharmaceutical-grade KLH production. They supplied major biotech/pharma companies with this critical reagent for vaccine development pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stellar Biotechnologies.